Updated
Updated · Detroit News · Aug 18
Shingles Vaccine Cuts Post-Herpetic Neuralgia Risk 90%, Eases Pain Even After Infection
Updated
Updated · Detroit News · Aug 18

Shingles Vaccine Cuts Post-Herpetic Neuralgia Risk 90%, Eases Pain Even After Infection

3 articles · Updated · Detroit News · Aug 18

Summary

  • Dr. Roach said people who get shingles despite vaccination often have milder illness, with the shot reducing acute pain severity even when it does not fully prevent infection.
  • The vaccine also cuts pain-medication use by 40% and shortens pain-med duration by 50%, while lowering the risk of post-herpetic neuralgia—persistent pain after shingles—by about 90%.
  • Valacyclovir and other antivirals can further reduce pain and inflammation, but work best when started within 24 hours of the rash and no later than 72 hours.
  • Eye involvement needs urgent ophthalmology care because shingles can be diagnosed quickly but also mistaken for other infections, and some eye complications may require intravenous antivirals.
  • Dr. Roach recommended shingles vaccination for all adults over 50 and for immunocompromised adults of any age unless a specific contraindication exists.

Insights

What hidden danger makes a simple shingles rash near your eye a race against the clock?
Could a common vaccine for a painful rash secretly protect your brain from dementia years later?
Why might fixing your gut bacteria be the unexpected key to finally conquering long COVID?